CA2421808C - Carbon dioxide-based bi-level cpap control - Google Patents
Carbon dioxide-based bi-level cpap control Download PDFInfo
- Publication number
- CA2421808C CA2421808C CA002421808A CA2421808A CA2421808C CA 2421808 C CA2421808 C CA 2421808C CA 002421808 A CA002421808 A CA 002421808A CA 2421808 A CA2421808 A CA 2421808A CA 2421808 C CA2421808 C CA 2421808C
- Authority
- CA
- Canada
- Prior art keywords
- carbon
- patient
- dioxide
- level
- breathing interface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
- A61M16/161—Devices to humidify the respiration air with means for measuring the humidity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0057—Pumps therefor
- A61M16/0066—Blowers or centrifugal pumps
- A61M16/0069—Blowers or centrifugal pumps the speed thereof being controlled by respiratory parameters, e.g. by inhalation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0816—Joints or connectors
- A61M16/0841—Joints or connectors for sampling
- A61M16/085—Gas sampling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
Abstract
A system and method of providing bi-level CPAP therapy is provided that incorporates an infrared carbon-dioxide sensor (124) to determine whether a patient is inhaling or exhaling. Patient exhalation causes the infrared light to be absorbed, while patient inhalation reduces the presence of carbon-dioxide causes little or no absorption of carbon-dioxide. The level of carbon-dioxide in an associated patient breathing interface is monitored for thresholds that trigger higher CPAP pressure upon inhalation and lower CPAP pressure upon exhalation.
Description
Carbon Dioxide-Based BI-LEVEL CPAP Control Cross-Reference to Related Applications [0001] This patent application is related to published United States Patent Application Nos. 2002/0104536 and 2005/0279358.
Field of the Invention [0002] The invention relates generally to the administration of constant positive airway pressure (CPAP) to treat obstructive sleep apnea, and more particularly, to methods and apparatuses for administering a higher CPAP upon inhalation and a lower CPAP upon exhalation.
Background of the Invention [0003] Obstructive sleep apnea is an airway breathing disorder caused by relaxation of the muscles of the upper airway to the point where the upper airway collapses or becomes obstructed by these same muscles. It is known that obstructive sleep apnea can be treated through the application of pressurized air to the nasal passages of a patient. The application of pressurized air forms a pneumatic splint in the upper airway of the patient thereby preventing the collapse or obstruction thereof.
Field of the Invention [0002] The invention relates generally to the administration of constant positive airway pressure (CPAP) to treat obstructive sleep apnea, and more particularly, to methods and apparatuses for administering a higher CPAP upon inhalation and a lower CPAP upon exhalation.
Background of the Invention [0003] Obstructive sleep apnea is an airway breathing disorder caused by relaxation of the muscles of the upper airway to the point where the upper airway collapses or becomes obstructed by these same muscles. It is known that obstructive sleep apnea can be treated through the application of pressurized air to the nasal passages of a patient. The application of pressurized air forms a pneumatic splint in the upper airway of the patient thereby preventing the collapse or obstruction thereof.
[0004] Within the treatment of obstructive sleep apnea, there are several known CPAP regimens including, for example, mono-level CPAP and bi-level CPAP. Mono-level CPAP involves the constant application of a single therapeutic CPAP level.
That is, through the entire breathing cycle, a single therapeutic positive air pressure is delivered to the patient.
While such a regimen is successful in treating obstructive sleep apnea, some patients experience discomfort when exhaling because of the level of positive air pressure being delivered to their airways during exhalation.
That is, through the entire breathing cycle, a single therapeutic positive air pressure is delivered to the patient.
While such a regimen is successful in treating obstructive sleep apnea, some patients experience discomfort when exhaling because of the level of positive air pressure being delivered to their airways during exhalation.
[0005] In response to this discomfort,. bi-level CPAP regimens were developed. Bi-level CPAP involves delivering a higher ~ s therapeutic CPAP during inhalation and a lower therapeutic CPAP
during exhalation. The higher therapeutic CPAP level is commonly known as inspiratory positive airway pressure or "IPAP." The lower therapeutic CPAP level is commonly known as expiratory positive airway pressure or "EPAP." Since the EPAP is lower than the IPAP, the patient needs to do less work during exhalation to exhale and thus experiences less discomfort, compared to the mono-level CPAP regimen.
during exhalation. The higher therapeutic CPAP level is commonly known as inspiratory positive airway pressure or "IPAP." The lower therapeutic CPAP level is commonly known as expiratory positive airway pressure or "EPAP." Since the EPAP is lower than the IPAP, the patient needs to do less work during exhalation to exhale and thus experiences less discomfort, compared to the mono-level CPAP regimen.
[0006] However, the development of bi-level CPAP significantly increased the sophistication of CPAP devices because the devices must accurately determine when the patient is inhaling and exhaling and to properly coordinate the IPAP and EPAP levels thereto. One approach is to determine the instantaneous and average flow rates of air being delivered to the patient and then to compare the two to determine whether a patient was inhaling or exhaling. If the instantaneous flow rate is greater than the average flow rate, the patient is deemed to be inhaling. If the instantaneous flow rate is less than the average flow rate, the patient is deemed to be exhaling. However, using the instantaneous and average flow rates of the air being delivered to the patient has several disadvantages including accuracy and response time. In this regard, the flow of air is generally turbulent and therefore difficult to measure accurately.
Additionally, leakages caused by loose fitting patient breathing interfaces such as, for example, nasal and mouth masks, contribute to the difficulty of determining accurate air flow rates. Closely connected thereto, the turbulent flow and difficulty of accurate measurement necessarily cause a slow response time in changing between IPAP and EPAP levels. Hence, a bi-level CPAP device that does not suffer from these deficiencies is highly desirable.
Additionally, leakages caused by loose fitting patient breathing interfaces such as, for example, nasal and mouth masks, contribute to the difficulty of determining accurate air flow rates. Closely connected thereto, the turbulent flow and difficulty of accurate measurement necessarily cause a slow response time in changing between IPAP and EPAP levels. Hence, a bi-level CPAP device that does not suffer from these deficiencies is highly desirable.
difficulty of accurate measurement necessarily cause a slow response time in changing between IPAP and EPAP levels. Hence, a bi-level CPAP device that does not suffer from these deficiencies is highly desirable.
Summary of the Invention [0007] According to one embodiment of the present invention, a carbon-dioxide sensor is used to determine whether a patient undergoing bi-level CPAP treatment for obstructive sleep apnea is inhaling or exhaling. The carbon-dioxide sensor uses infrared light to determine the presence or absence of carbon-dioxide in a patient breathing interface such as, for example, a nasal and mouth mask, worn by the patient. In this regard, the carbon-dioxide sensor includes, for example, an infrared light emitter and detector separated by an air gap. Patient exhalation results in carbon-dioxide being present in the air gap. This causes less infrared light to be transmitted to the detector due to the carbon-dioxide absorbing a portion of the infrared light. Conversely, patient inhalation results in little or no carbon-dioxide being present in the air gap. This causes more infrared light to be transmitted to the detector because there is little or no carbon-dioxide present to absorb the infrared light. Through such detection, the logic of the present invention coordinates the IPAP
and EPAP'levels to provide the patient with a comfortable bi-level CPAP regimen.
Summary of the Invention [0007] According to one embodiment of the present invention, a carbon-dioxide sensor is used to determine whether a patient undergoing bi-level CPAP treatment for obstructive sleep apnea is inhaling or exhaling. The carbon-dioxide sensor uses infrared light to determine the presence or absence of carbon-dioxide in a patient breathing interface such as, for example, a nasal and mouth mask, worn by the patient. In this regard, the carbon-dioxide sensor includes, for example, an infrared light emitter and detector separated by an air gap. Patient exhalation results in carbon-dioxide being present in the air gap. This causes less infrared light to be transmitted to the detector due to the carbon-dioxide absorbing a portion of the infrared light. Conversely, patient inhalation results in little or no carbon-dioxide being present in the air gap. This causes more infrared light to be transmitted to the detector because there is little or no carbon-dioxide present to absorb the infrared light. Through such detection, the logic of the present invention coordinates the IPAP
and EPAP'levels to provide the patient with a comfortable bi-level CPAP regimen.
[0008] In a first embodiment, the level of carbon-dioxide is monitored to determine whether it is above or below a threshold parameter or value. If the level of carbon dioxide is above the threshold, the patient is exhaling and an EPAP level is provided.
If the level of carbon-dioxide is below the threshold, the patient is inhaling and an IPAP level is provided to the patient. Hence, the same threshold is used once to trigger EPAP and again to trigger IPAP.
If the level of carbon-dioxide is below the threshold, the patient is inhaling and an IPAP level is provided to the patient. Hence, the same threshold is used once to trigger EPAP and again to trigger IPAP.
[0009] In a second embodiment, monostable timer control is used to trigger the EPAP and IPAP. In this regard, the monostable timer is trigger to its fixed duration on state when the level of carbon-dioxide is decreasing and falls below a threshold parameter or value. Once this happens, the patient is inhaling and an IPAP
level is provided. Upon expiration of the monostable timer's fixed duration on state, patient exhalation is assumed and an EPAP level is provided until the monostable timer is once again triggered.
level is provided. Upon expiration of the monostable timer's fixed duration on state, patient exhalation is assumed and an EPAP level is provided until the monostable timer is once again triggered.
[0010] It is therefore an object of the present invention to provide a system and method of providing a higher positive airway pressure breathing gas during patient inhalation and a lower positive airway pressure breathing gas during patient exhalation.
Brief Description of the Drawings [0011] In the accompanying drawings which are incorporated in and constitute a part of the specification, embodiments of the invention are illustrated, which, together with a general description of the invention given above, and the detailed description given below, serve to example the principles of this invention.
Brief Description of the Drawings [0011] In the accompanying drawings which are incorporated in and constitute a part of the specification, embodiments of the invention are illustrated, which, together with a general description of the invention given above, and the detailed description given below, serve to example the principles of this invention.
[0012] Figure 1 is a functional block diagram of a system of the present invention having a carbon-dioxide sensor integral with a nasal mask.
[0013] Figure 2 is a functional block diagram of a system of the present invention having a carbon-dioxide sensor external to a nasal mask.
[0014] Figure 3 is a functional block diagram of a system of the present invention having a carbon-dioxide sensor external to a nasal mask and indi.rectly connected thereto.
[0015] Figure 4 is a functional block diagram of a system of the present invention having a carbon-dioxide sensor that is connected to a nasal mask with optical fibers.
[0016] Figure 5 is a flow chart of the bi-level CPAP logic of the present invention.
[0017] Figure 6 is a schematic diagram of a comparator circuit of the present invention.
[0018] Figure 7 illustrates graphs of the input and output signals of the comparator circuit of Figure S.
[0019] Figure 8 illustrates a monostable timer control embodiment of the present invention.
[0020] Figure 9 is a flowchart of the monostable timer control logic of the present invention.
Detailed Description of illustrated Embodiment [0021] Illustrated in Figure 1 is a first bi-level CPAP system 100 of the present invention. The system has a bi-level CPAP
apparatus 101 and a patient breathing interface 114. The bi-level CPAP apparatus 101 has a micro-controller 102 with associated bi-level CPAP logic 104. The micro-controller 102 interfaces with a plurality of components including input/output devices 110, analog-to-digital converter (ADC) 132, and blower driver 106.
Input/Output devices 110 include, for example, controls that allow a clinician or doctor to set the IPAP and EPAP levels in micro-controller 102 and in bi-level CPAP logic 104. Blower driver 106 interfaces with and drives blower 108 through a range of variable speeds that result in a range of variable air pressures that define the IPAP and EPAP levels. The blower 108 preferably has a motor and a fan and is driven by a pulse-width modulated (PWM) signal wherein the pulse width or duty cycle defines the variable speed and pressure of the blower. Alternatively, an adjustable valve can be used to vary the bi-level CPAP
pressure between IPAP and CPAP levels such as described in US
Patent No. 5,433,193.
Detailed Description of illustrated Embodiment [0021] Illustrated in Figure 1 is a first bi-level CPAP system 100 of the present invention. The system has a bi-level CPAP
apparatus 101 and a patient breathing interface 114. The bi-level CPAP apparatus 101 has a micro-controller 102 with associated bi-level CPAP logic 104. The micro-controller 102 interfaces with a plurality of components including input/output devices 110, analog-to-digital converter (ADC) 132, and blower driver 106.
Input/Output devices 110 include, for example, controls that allow a clinician or doctor to set the IPAP and EPAP levels in micro-controller 102 and in bi-level CPAP logic 104. Blower driver 106 interfaces with and drives blower 108 through a range of variable speeds that result in a range of variable air pressures that define the IPAP and EPAP levels. The blower 108 preferably has a motor and a fan and is driven by a pulse-width modulated (PWM) signal wherein the pulse width or duty cycle defines the variable speed and pressure of the blower. Alternatively, an adjustable valve can be used to vary the bi-level CPAP
pressure between IPAP and CPAP levels such as described in US
Patent No. 5,433,193.
[0022] System 100 also includes a patient breathing interface 114, such as a mask, that is worn by a patient that is to receive bi-level CPAP therapy. Patient breathing interface 114 is connected to blower 108 through supply tubing 112, which supplies the IPAP and EPAP levels to the patient from the CPAP apparatus 101. In the present embodiment, patient breathing interface 114 has a carbon-dioxide sensor 116 integral therewith for detecting the presence of carbon-dioxide in the mask.
[0023] Carbon-dioxide sensor 116 preferably includes an infrared light emitter 118 and an infrared light detector 124.
Infrared light emitter 118 is preferably an incandescent light source emitting light in the infrared frequency range.
However, infrared light emitting diodes can also be employed.
Infrared light detector 124 is of conventional design.
Infrared light emitter 118 is separated from infrared light detector 124 by an air gap such that infrared light 122 emitted from emitter 118 is directed across the air gap and towards detector 124.
Infrared light emitter 118 is preferably an incandescent light source emitting light in the infrared frequency range.
However, infrared light emitting diodes can also be employed.
Infrared light detector 124 is of conventional design.
Infrared light emitter 118 is separated from infrared light detector 124 by an air gap such that infrared light 122 emitted from emitter 118 is directed across the air gap and towards detector 124.
[0024] In this regard, it is known that carbon-dioxide absorbs light in the infrared energy spectrum. See, for example, US Patent No. 4,648,396 to Raemer. Hence, when a gas having carbon-dioxide is present in the air gap between infrared light emitter 118 and detector 124, less infrared light is transmitted to detector 124 than if no carbon-dioxide was present in the air gap. This is indicated by the output (i.e., signal 128) of detector 124 falling to a level indicative of the amount of infrared light that is not being absorbed by the carbon-dioxide. In this manner, carbon-dioxide sensor 116 senses the amount of carbon-dioxide present.
[0025] Carbon-dioxide sensor 116 further includes an input port 120 and in output port 126. Input port 120 allows gases present in patient breathing interface 114 to pass into carbon-dioxide sensor 116 and between the air gap separating infrared light emitter 118 and detector 124 for carbon-dioxide detection. Output port 126 allows venting of the gases in carbon-dioxide sensor 116 to the outside atmosphere. Configured as such, carbon-dioxide sensor 116 also performs a venting function provided for by most conventional patient breathing interfaces.
[0026] As shown in Figure 1, bi-level CPAP apparatus 101 is in circuit communication with infrared light emitter 118 and detector 124. More particularly, micro-controller 102 drives infrared light emitter 118 on and off through signal line 130 and conventional drive circuitry (not shown) . Micro-controller 102 also reads the output of infrared light detector 124 through signal line 128 and ADC 132. In this manner, micro-controller 102 controls carbon-dioxide sensor 116 and reads its output signal to thereby determine the presence or absence of carbon-dioxide in patient breathing interface 114. As will be described in more detail in connection with the logic of Figure 4, the presence of carbon-dioxide indicates that a wearer of patient breathing interface 114 is exhaling and the absence of carbon-dioxide indicates that the wearer is inhaling. By knowing when the patient is inhaling and exhaling, micro-controller 102 and bi-level CPAP logic 104 can vary the air pressure delivered by blower 108 to the proper IPAP and EPAP levels set by the clinician or doctor.
[0027] Figure 2 illustrates a bi-level CPAP system 200 that is similar system 100 of Figure 1, except that carbon-dioxide sensor 116 is external to theqpatient breathing interface 114. In system 200, carbon-dioxide sensor 116 has a housing 202 that is connected to patient breathing interface 114 through tubing 204. Tubing 204 functions as the input port to carbon-dioxide sensor 116 by delivering gases thereto from patient breathing interface 114.
Housing 202 also includes an output port 206 that allows venting of the gases in carbon-dioxide sensor 116 to the outside atmosphere.
Housing 202 also includes an output port 206 that allows venting of the gases in carbon-dioxide sensor 116 to the outside atmosphere.
[0028] Figure 3 illustrates a bi-level CPAP system 300 that is similar to system 200 of Figure 2, except that carbon-dioxide sensor 116 is not directly connected to patient breathing interface 114. Rather, carbon-dioxide detector 116 is indirectly connected to patient breathing interface 114 via sensor tubing 302 and supply tubing 112. In all other aspects, systems 200 and 300 are similar to system 100 of Figure 1.
[0029] Illustrated in Figure 4 is a system 400 of the present invention that employs optical fibers to carry infrared light to and from patient breathing interface 114. In particular, carbon-dioxide sensor 116 is external to patient breathing interface 114 and preferably located within bi-level CPAP apparatus 101. A
plurality of optical fibers carry infrared light from infrared light emitter 118 to patient breathing interface 114 and back to infrared light detector 124. Within patient breathing interface 114, optical fibers 402 and 404 are terminated such that infrared light exiting optical fiber 402 is ultimately directed across an air gap and to optical fiber 404 for return to infrared light detector 124. The fiber optic terminations and air gap are preferably disposed across one or more of the venting mechanisms (i.e., one or more holes or vents) of patient breathing interface 114. In this regard, exhaled gases that are normally vented through such mechanisms can be monitored by carbon-dioxide sensor 116. It should also be noted in Figure 4 that optical fibers 402 and 404 can be connected in a similar manner to supply tube 112 rather patient breathing interface 114. Configured as such, system 400 is particularly advantageous because it does not require the use of additional tubing and allows the carbon-dioxide sensor 116 to be housed with bi-level CPAP apparatus 101.
plurality of optical fibers carry infrared light from infrared light emitter 118 to patient breathing interface 114 and back to infrared light detector 124. Within patient breathing interface 114, optical fibers 402 and 404 are terminated such that infrared light exiting optical fiber 402 is ultimately directed across an air gap and to optical fiber 404 for return to infrared light detector 124. The fiber optic terminations and air gap are preferably disposed across one or more of the venting mechanisms (i.e., one or more holes or vents) of patient breathing interface 114. In this regard, exhaled gases that are normally vented through such mechanisms can be monitored by carbon-dioxide sensor 116. It should also be noted in Figure 4 that optical fibers 402 and 404 can be connected in a similar manner to supply tube 112 rather patient breathing interface 114. Configured as such, system 400 is particularly advantageous because it does not require the use of additional tubing and allows the carbon-dioxide sensor 116 to be housed with bi-level CPAP apparatus 101.
[0030] Referring now to Figure 5, a flowchart illustrating the bi-level CPAP logic 104 of the present invention is shown. The bi-level CPAP logic 104 is executed by micro-controller 102. The logic starts in step 502 where micro-controller 102 reads the value of carbon-dioxide sensor 116 output signal 128.
[0031] In step 504, the logic determines if carbon-dioxide is present in the patient breathing interface by comparing the value of the sensor output signal 128 against a threshold parameter or value. The threshold parameter or value is preferably a carbon-dioxide level within the patient breathing interface that is representative of the state of exhalation by the patient. If the value of sensor output signal 128 is less than the threshold parameter, then carbon-dioxide is sufficiently present and, therefore, the patient is exhaling. In this scenario, the logic advances to step 506. In step 506, micro-controller 102 directs blower 108 to reduce its output pressure to EPAP level by preferably decreasing the duty cycle of the blower's PWM driving signal. After step 506, the logic loops back to step 502 and once again reads the value of carbon-dioxide sensor 116 output signal 128.
[0032] However, if in step 504 the value of sensor output signal 128 is greater than the threshold parameter, then carbon-dioxide is deemed to be sufficiently absent and, therefore, the patient is inhaling. In this scenario, the logic advances to step 508 where the micro-controller 102 directs blower 108 to increase its output pressure to IPAP level by preferably increasing the duty cycle of the blower's PWM driving signal. After step 508, the logic loops back to step 502 and once gain reads the carbon-dioxide sensor 116 output signal 128 to determine the appropriate CPAP level (i.e., IPAP or EPAP). In this manner, micro-controller 102 reads carbon-dioxide sensor 116 to determine the presence and absence of carbon-dioxide and to properly coordinate the IPAP and EPAP levels with the patient's inspiratory and expiratory cycles.
[0033] Referring now to Figure 6, an analog comparator circuit 600 is shown that can be used as an alternative to ADC 132. The circuit 600 preferably includes an operational amplifier 602 that receives sensor output signal 128 at its positive input terminal and a reference or threshold voltage signal 604 at its negative input terminal. The output 606 of operational amplifier 602 is preferably connected to micro-controller 102 or other CPAP control circuitry.
[0034] As shown in graphs 700 and 702 of Figure 7, whenever sensor output signal 128 is greater than reference or threshold parameter, as represented by voltage signal 604, comparator 500 output signal 606 preferably increases to a positive voltage level.
This indicates that carbon-dioxide is sufficiently absent so as to signify that the patient is inhaling and that blower 108 should provide the prescribed IPAP level. Whenever sensor output signal 128 is less than the reference or threshold parameter 604, comparator 600 output signal 606 preferably falls to a lower voltage level. This indicates that carbon-dioxide is sufficiently present so as to signify that the patient is exhaling and that blower 108 should provide the prescribed EPAP level. Alternately, threshold parameter 604 can be in the form of first and second threshold parameter: one for inhalation detection and one for exhalation detection. This configuration compensates for potential differences in carbon-dioxide inhalation and exhalation thresholds.
It 1 [0035] Referring now to Figure 8, a second embodiment of the present invention is illustrated that incorporates a monostable timer control to coordinate the IPAP and EPAP levels with the patient's breathing cycles. The monostable timer control can be implemented in any of the CPAP embodiments of Figures 1 through 4 wherein the monostable timer control is incorporated into bi-level CPAP logic 104.
This indicates that carbon-dioxide is sufficiently absent so as to signify that the patient is inhaling and that blower 108 should provide the prescribed IPAP level. Whenever sensor output signal 128 is less than the reference or threshold parameter 604, comparator 600 output signal 606 preferably falls to a lower voltage level. This indicates that carbon-dioxide is sufficiently present so as to signify that the patient is exhaling and that blower 108 should provide the prescribed EPAP level. Alternately, threshold parameter 604 can be in the form of first and second threshold parameter: one for inhalation detection and one for exhalation detection. This configuration compensates for potential differences in carbon-dioxide inhalation and exhalation thresholds.
It 1 [0035] Referring now to Figure 8, a second embodiment of the present invention is illustrated that incorporates a monostable timer control to coordinate the IPAP and EPAP levels with the patient's breathing cycles. The monostable timer control can be implemented in any of the CPAP embodiments of Figures 1 through 4 wherein the monostable timer control is incorporated into bi-level CPAP logic 104.
[0036] In this regard, a monostable timer has one stable state and one quasi-stable state. For example, a timer having a variable off time and a fixed on time, or vice-versa, is generally known as a monostable timer. In the present embodiment, the variable off time of'the monostable timer defines the exhalation state and the fixed on time defines the inhalation state. The opposite configuration can also be used. The monostable timer of the present invention also has a trigger in the form of a carbon-dioxide threshold level.
[0037] Referring now to Figure 8 more particularly, the incorporation of a monostable timer control for governing the relationship between the level of carbon-dioxide associated with the patient breathing apparatus 114 and the inhalation and exhalation breathing states is generally illustrated at 800. In this regard, a representative carbon-dioxide level is shown over several patient breathing cycles is indicated by curve 802. As is commonly understood, more carbon-oxide is present in the patient breathing interface during exhalation than inhalation. Also illustrated is a threshold parameter 804 that serves to trigger the monostable timer of the present embodiment. Threshold parameter 804 is preferably defined as a carbon-dioxide level seen at the trailing or decreasing portion of the carbon-dioxide curve 802.
The trigger points established by threshold parameter 804 are further illustrated by trigger lines 806. Hence, during patient exhalation, the level of carbon-dioxide increases over time to a certain level in the patient breathing interface or associated tubing. Venting by the patient breathing interface causes the carbon-dioxide level to begin decreasing. However, it is not until patient inhalation does the carbon-dioxide level decrease quickly over time so as to fall below threshold parameter 804 and trigger the monostable timer at 806.
The trigger points established by threshold parameter 804 are further illustrated by trigger lines 806. Hence, during patient exhalation, the level of carbon-dioxide increases over time to a certain level in the patient breathing interface or associated tubing. Venting by the patient breathing interface causes the carbon-dioxide level to begin decreasing. However, it is not until patient inhalation does the carbon-dioxide level decrease quickly over time so as to fall below threshold parameter 804 and trigger the monostable timer at 806.
[0038] In the present embodiment, during patient exhalation, the monostable timer is in its off state toff and micro-controller 102 directs blower 108 to provide an EPAP level to patient breathing interface 114. By providing an EPAP level, the patient can more comfortably exhale against a lower positive airway pressure. Once the carbon-dioxide level 802 rises and then falls below threshold parameter 804 to trigger the monostable timer at 806, the monostable timer changes to its on state ton for a fixed, predetermined time duration. This fixed, predetermined on time duration ton represents patient inhalation 810. The fixed, predetermined on time duration ton is based on the observation that during sleep most patient inhalation cycles have the same, or very nearly the same, duration. The monostable timer change of state from toff to ton causes micro-controller 102 to direct blower 108 to provide an IPAP level to the patient breathing interface 114 for the duration of time defined by ton. By providing an IPAP level, a higher positive airway pressure is delivered to the patient during inhalation. Upon expiration of the time ton, the monostable timer changes to its off state, as represented by lines 808. As described above, this causes micro-controller 102 to direct blower 108 to provide an EPAP level to the patient breathing interface 114 because the patient is about to exhale. The process is then repeated for the next patient breathing cycle.
[0039] Hence, the monostable timer control of the present invention provides a single trigger method for coordinating IPAP
and EPAP levels withxpatient inhalation and exhalation. The trigger is defined by monitoring the carbon-dioxide level associated with the patient breathing interface for a falling level that crosses a predetermined threshold. The trigger defines a change in state of the monostable timer from an off state to an on state. The off state represents patient exhalation and causes the present invention to provide an EPAP level. The on state represents patient inhalation and causes the present invention to provide an IPAP level for a fixed, predetermined time duration.
Upon expiration of the fixed, predetermined time duration, the present invention lowers the pressure back to EPAP level for patient exhalation. The process is repeated for each patient breathing cycle.
and EPAP levels withxpatient inhalation and exhalation. The trigger is defined by monitoring the carbon-dioxide level associated with the patient breathing interface for a falling level that crosses a predetermined threshold. The trigger defines a change in state of the monostable timer from an off state to an on state. The off state represents patient exhalation and causes the present invention to provide an EPAP level. The on state represents patient inhalation and causes the present invention to provide an IPAP level for a fixed, predetermined time duration.
Upon expiration of the fixed, predetermined time duration, the present invention lowers the pressure back to EPAP level for patient exhalation. The process is repeated for each patient breathing cycle.
[0040] Referring now to Figure 9, a flowchart illustrating the monostable timer control of bi-level CPAP logic 104 is shown. The logic commences in step 902 where the carbon-dioxide level associated with the patient breathing interface is sensed or monitored via carbon-dioxide sensor 116. Initially, the present invention provides an EPAP level until triggered. The logic then proceeds to step 904 where the sensed carbon-dioxide level is tested to determine whether it is increasing or decreasing. If the carbon-dioxide level is increasing, then the patient is exhaling and the EPAP level will continue to be provided. However, if the carbon-dioxide level is decreasing, the patient's breathing cycle is then starting a transition from exhalation to inhalation and the logic proceeds to step 906.
[0041] In step 906, the logic tests to determine whether the decreasing carbon-dioxide level has crossed a threshold parameter or value representing the state of patient inhalation. If the decreasing carbon-dioxide level has not crossed the threshold parameter, the logic loops back to step 902 to once again monitor the carbon-dioxide level. However, if the decreasing carbon-dioxide level has fallen to or below the threshold, then the logic advances to step 908 where the monostable timer is triggered to its on state. As described above, triggering the monostable timer causes an IPAP level to be delivered to the patient breathing interface for a fixed, predetermined time duration. Upon expiration of the fixed, predetermined time duration, the logic advances to step 910 where the monostable timer changes to its off state and an EPAP level is once again delivered to the patient breathing interface. After step 910, the logic loops back to step 902 and the process repeats. In this manner, a signal trigger is used to provide an IPAP level to a patient for a, fixed, predetermined time duration for inhalation and an EPAP level to the patient for the duration of exhalation.
[0042] While the present invention has been illustrated by the description of embodiments thereof, and while the embodiments have been described in considerable detail, it is not the intention of application to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. For example, the carbon-dioxide level can be quantitatively measured and used to raise or lower the IPAP or EPAP level in a step-wise fashion until obstructive sleep apnea no longer occurs. Still further, the carbon-dioxide sensor 116 of the present invention can be substituted with a temperature or humidity sensor. More specifically, exhalation and inhalation can be distinguished based on the temperature of the inhaled and exhaled gases. In this regard, exhaled gases have a higher temperature than inhaled gases and the temperature sensor would detect such a difference.
Exhalation and inhalation can also be distinguished based on the water content or humidity level of the inhaled and exhaled gases.
In this regard, exhaled gases have a higher humidity level than inhaled gases and the humidity sensor would detect such a difference. Still further, the present invention can be implemented with a microprocessor controlled system or discrete circuit element system. For example, a discrete circuit such as, for example, a Schmitt Trigger can be used to sense the carbon-dioxide level. Therefore, the invention, in its broader aspects, is not limited to the specific details, the representative apparatus, and illustrative examples shown and described.
Accordingly, departures may be made from such details without departing from the spirit or scope of the applicant's general inventive concept.
Exhalation and inhalation can also be distinguished based on the water content or humidity level of the inhaled and exhaled gases.
In this regard, exhaled gases have a higher humidity level than inhaled gases and the humidity sensor would detect such a difference. Still further, the present invention can be implemented with a microprocessor controlled system or discrete circuit element system. For example, a discrete circuit such as, for example, a Schmitt Trigger can be used to sense the carbon-dioxide level. Therefore, the invention, in its broader aspects, is not limited to the specific details, the representative apparatus, and illustrative examples shown and described.
Accordingly, departures may be made from such details without departing from the spirit or scope of the applicant's general inventive concept.
Claims (45)
1. A system for administering a breathing gas to a patient breathing interface comprising:
(a) a blower for providing positive pressure breathing gas;
(b) a controller in circuit communication with the blower;
(c) an infrared light emitter and detector in circuit communication with the controller for detecting the level of carbon-dioxide associated with the patient breathing interface; and (d) logic for increasing and decreasing the pressure of the positive pressure breathing gas based on the level of carbon-dioxide detected to maintain open the airway of a patient.
(a) a blower for providing positive pressure breathing gas;
(b) a controller in circuit communication with the blower;
(c) an infrared light emitter and detector in circuit communication with the controller for detecting the level of carbon-dioxide associated with the patient breathing interface; and (d) logic for increasing and decreasing the pressure of the positive pressure breathing gas based on the level of carbon-dioxide detected to maintain open the airway of a patient.
2. The system of claim 1 wherein the logic for increasing and decreasing the pressure of the positive pressure breathing gas based on the level of carbon-dioxide associated with the patient breathing interface comprises logic for comparing the level of carbon-dioxide associated with the patient breathing interface to a threshold parameter.
3. The system of claim 1 further comprising a timer having a variable off time period and predetermined on time period.
4. The system of claim 1 further comprising optical fibers coupled to the infrared emitter and detector.
5. The system of claim 1 wherein the infrared emitter and detector are located within a housing accommodating the controller.
6. The system of claim 1 wherein the infrared emitter and detector are located within the patient breathing interface.
7. The system of claim 1 wherein the infrared emitter and detector are located proximate to a vent of the patient breathing interface.
8. A system for administering a breathing gas to a patient via a patient breathing interface comprising:
(a) a subsystem capable of providing variable positive pressure breathing gas to the patient breathing interface;
(b) a controller in circuit communication with the subsystem;
(c) a carbon dioxide detector in communication with the patient breathing interface for detecting whether the patient is inhaling or exhaling; and (d) logic in communication with the carbon dioxide detector and the subsystem to cause the subsystem to provide a first pressure of the positive pressure breathing gas if the patient is inhaling and to provide a second pressure of the positive pressure breathing gas if the patient is exhaling.
(a) a subsystem capable of providing variable positive pressure breathing gas to the patient breathing interface;
(b) a controller in circuit communication with the subsystem;
(c) a carbon dioxide detector in communication with the patient breathing interface for detecting whether the patient is inhaling or exhaling; and (d) logic in communication with the carbon dioxide detector and the subsystem to cause the subsystem to provide a first pressure of the positive pressure breathing gas if the patient is inhaling and to provide a second pressure of the positive pressure breathing gas if the patient is exhaling.
9. The system of claim 8, wherein the subsystem comprises a blower.
10. The system of claim 9, wherein the subsystem comprises a driver capable of driving the blower through a range of variable speeds.
11. The system of claim 9, wherein the subsystem comprises an adjustable valve responsive to the logic.
12. The system of claim 8, wherein the detector comprises an infrared light emitter and detector.
13. The system of claim 8, wherein the logic is capable of comparing a level of carbon dioxide detected in the patient breathing interface by the detector to a threshold parameter.
14. The system of claim 13, further comprising at least one input device in communication with the logic to enable input of a desired value for the threshold parameter.
15. The system of claim 8, further comprising an input device in communication with the logic to enable input of a desired value for at least one of the first pressure and the second pressure.
16. The system of claim 8, further comprising a device in communication with the logic and capable of causing the subsystem to provide the first pressure of the positive pressure breathing gas for a fixed time period.
17. The system of claim 16, wherein the device comprises a timer.
18. A system for administering breathing gas to a patient breathing interface, comprising:
(a) a variable speed blower providing variable positive pressure breathing gas to the patient breathing interface;
(b) a controller in circuit communication with the blower;
(c) an infrared light emitter and detector in communication with the patient breathing interface for detecting the level of carbon-dioxide associated with the patient breathing interface to determine whether the patient is inhaling or exhaling;
(d) logic in communication with the infrared light detector and the variable speed blower to cause the variable speed blower to provide a first pressure of the positive pressure breathing gas if the patient is inhaling and to provide a second pressure of the positive pressure breathing gas if the patient is exhaling; and (e) at least one input device in communication with the logic to enable input of a desired value for a threshold parameter and at least one of the first pressure and the second pressure;
wherein the logic is capable of comparing a level of carbon dioxide detected in the patient breathing interface by the detector to the threshold parameter.
(a) a variable speed blower providing variable positive pressure breathing gas to the patient breathing interface;
(b) a controller in circuit communication with the blower;
(c) an infrared light emitter and detector in communication with the patient breathing interface for detecting the level of carbon-dioxide associated with the patient breathing interface to determine whether the patient is inhaling or exhaling;
(d) logic in communication with the infrared light detector and the variable speed blower to cause the variable speed blower to provide a first pressure of the positive pressure breathing gas if the patient is inhaling and to provide a second pressure of the positive pressure breathing gas if the patient is exhaling; and (e) at least one input device in communication with the logic to enable input of a desired value for a threshold parameter and at least one of the first pressure and the second pressure;
wherein the logic is capable of comparing a level of carbon dioxide detected in the patient breathing interface by the detector to the threshold parameter.
19. A system for administering a breathing gas to a patient via a patient breathing interface comprising:
(a) means for providing variable positive pressure breathing gas to the patient breathing interface;
(b) means for determining whether the patient is inhaling or exhaling based on detection of carbon dioxide in the patient breathing interface; and (c) means for maintaining open the airway of the patient by causing a first pressure of the positive pressure breathing gas to be provided to the patient breathing interface if the patient is inhaling and for causing a second pressure of the positive pressure breathing gas to be provided to the patient breathing interface if the patient is exhaling.
(a) means for providing variable positive pressure breathing gas to the patient breathing interface;
(b) means for determining whether the patient is inhaling or exhaling based on detection of carbon dioxide in the patient breathing interface; and (c) means for maintaining open the airway of the patient by causing a first pressure of the positive pressure breathing gas to be provided to the patient breathing interface if the patient is inhaling and for causing a second pressure of the positive pressure breathing gas to be provided to the patient breathing interface if the patient is exhaling.
20. The system of claim 19, further comprising means for detecting carbon dioxide.
21. Use of the system according to any one of claims 1 to 20 for providing a breathing gas, the system suitable for:
sensing a carbon-dioxide level associated with a patient breathing interface;
determining if the level of carbon-dioxide is increasing or decreasing;
if the level is decreasing, determining if the level of carbon-dioxide has crossed a threshold parameter;
if the carbon-dioxide level has crossed the threshold parameter, increasing the breathing gas pressure; and decreasing the breathing gas pressure after a predetermined period of time.
sensing a carbon-dioxide level associated with a patient breathing interface;
determining if the level of carbon-dioxide is increasing or decreasing;
if the level is decreasing, determining if the level of carbon-dioxide has crossed a threshold parameter;
if the carbon-dioxide level has crossed the threshold parameter, increasing the breathing gas pressure; and decreasing the breathing gas pressure after a predetermined period of time.
22. The use according to claim 21 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises sensing the carbon-dioxide level using infrared light.
23. The use according to claim 21 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises emitting infrared light within the patient breathing interface.
24. The use according to claim 23 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises detecting infrared light within the patient breathing interface.
25. The use according to claim 23 wherein emitting comprises emitting infrared light into a fiber optic cable connected to the patient breathing interface.
26. The use according to claim 24 wherein detecting infrared light comprises sensing the infrared light in a fiber optic cable coupled to the patient breathing interface.
27. The use according to claim 21 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises sensing the carbon-dioxide level vented from the patient breathing interface.
28. The use according to claim 21 wherein the system is suitable for initiating a timer if the carbon-dioxide level has crossed the threshold parameter.
29. The use according to claim 28 wherein decreasing the breathing gas pressure after a predetermined period of time comprises decreasing the breathing gas pressure upon expiration of the timer.
30. Use of the system according to any one of claims 1 to 20 for providing a breathing gas, the system suitable for:
sensing a carbon-dioxide level associated with a patient breathing interface;
determining if the sensed level of carbon-dioxide is increasing or decreasing;
if the sensed carbon-dioxide level is increasing, determining if the sensed carbon-dioxide level has crossed a first threshold parameter;
if the sensed carbon-dioxide level has crossed the first threshold parameter, decreasing the breathing gas pressure;
if the sensed carbon-dioxide level is decreasing, determining if the sensed carbon-dioxide level has crossed a second threshold parameter; and if the sensed carbon-dioxide level has crossed the second threshold parameter, increasing the breathing gas pressure.
sensing a carbon-dioxide level associated with a patient breathing interface;
determining if the sensed level of carbon-dioxide is increasing or decreasing;
if the sensed carbon-dioxide level is increasing, determining if the sensed carbon-dioxide level has crossed a first threshold parameter;
if the sensed carbon-dioxide level has crossed the first threshold parameter, decreasing the breathing gas pressure;
if the sensed carbon-dioxide level is decreasing, determining if the sensed carbon-dioxide level has crossed a second threshold parameter; and if the sensed carbon-dioxide level has crossed the second threshold parameter, increasing the breathing gas pressure.
31. The use according to claim 30 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises sensing the carbon-dioxide level using infrared light.
32. The use according to claim 30 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises emitting infrared light within the patient breathing interface.
33. The use according to claim 32 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises detecting infrared light within the patient breathing interface.
34. The use according to claim 32 wherein emitting comprises emitting infrared light into a fiber optic cable coupled to the patient breathing interface.
35. The use according to claim 34 wherein detecting infrared light comprises sensing the infrared light in a fiber optic cable coupled to the patient breathing interface.
36. The use according to claim 30 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises sensing the carbon-dioxide level vented from the patient breathing interface.
37. Use of the system according to any one of claims 1 to 20 for providing a breathing gas, the system suitable for:
sensing a carbon-dioxide level associated with a patient breathing interface;
determining if the sensed level of carbon-dioxide is increasing or decreasing;
if the sensed level of carbon-dioxide is decreasing, determining whether the sensed level of carbon-dioxide is at or below a threshold level;
if the sensed level of carbon-dioxide is at or below the threshold level, increasing pressure of the breathing gas for a fixed period of time; and decreasing the pressure of the breathing gas upon expiration of the fixed period of time.
sensing a carbon-dioxide level associated with a patient breathing interface;
determining if the sensed level of carbon-dioxide is increasing or decreasing;
if the sensed level of carbon-dioxide is decreasing, determining whether the sensed level of carbon-dioxide is at or below a threshold level;
if the sensed level of carbon-dioxide is at or below the threshold level, increasing pressure of the breathing gas for a fixed period of time; and decreasing the pressure of the breathing gas upon expiration of the fixed period of time.
38. The use according to claim 37 wherein increasing the pressure of the breathing gas for a fixed period of time comprises initiating a timer.
39. The use according to claim 37 wherein sensing a carbon-dioxide level associated with a patient breathing interface comprises sensing a carbon-dioxide level with infrared light.
40. The use according to claim 39 wherein sensing a carbon-dioxide level with infrared light comprises sensing a carbon-dioxide level vented from the patient breathing interface.
41. Use of the system according to any one of claims 1 to 20 suitable for administering a CPAP, the system suitable for:
monitoring the level of carbon-dioxide vented from a patient breathing interface;
if the level of carbon-dioxide vented is decreasing, determining if the level of carbon-dioxide is at or below a threshold value;
if the level of carbon-dioxide vented is at or below the threshold value, providing a first positive airway pressure for a fixed period of time; and upon the expiration of the fixed period of time providing a second positive airway pressure.
monitoring the level of carbon-dioxide vented from a patient breathing interface;
if the level of carbon-dioxide vented is decreasing, determining if the level of carbon-dioxide is at or below a threshold value;
if the level of carbon-dioxide vented is at or below the threshold value, providing a first positive airway pressure for a fixed period of time; and upon the expiration of the fixed period of time providing a second positive airway pressure.
42. Use of the system according to any one of claims 1 to 20 for treating a patient with CPAP therapy.
43. Use of the system according to any one of claims 1 to 20 for providing a breathing gas to a patient in need thereof.
44. Use of the system according to any one of claims 1 to 20 for treating obstructive sleep apnea.
45. Use of the system according to any one of claims 1 to 20 for maintaining a positive pressure sufficient to sustain open an airway of a patient in need thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23612300P | 2000-09-28 | 2000-09-28 | |
US60/236,123 | 2000-09-28 | ||
PCT/US2001/030768 WO2002026287A2 (en) | 2000-09-28 | 2001-09-27 | Carbon dioxide-based bi-level cpap control |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2421808A1 CA2421808A1 (en) | 2002-04-04 |
CA2421808C true CA2421808C (en) | 2009-12-15 |
Family
ID=22888216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002421808A Expired - Fee Related CA2421808C (en) | 2000-09-28 | 2001-09-27 | Carbon dioxide-based bi-level cpap control |
Country Status (6)
Country | Link |
---|---|
US (2) | US6990980B2 (en) |
EP (1) | EP1322367A4 (en) |
AU (2) | AU2001293203B2 (en) |
CA (1) | CA2421808C (en) |
NZ (1) | NZ524990A (en) |
WO (1) | WO2002026287A2 (en) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ524990A (en) | 2000-09-28 | 2005-02-25 | Invacare Corp | Carbon dioxide-based BI-level CPAP control |
DE10139881B4 (en) * | 2001-08-20 | 2017-06-08 | Resmed R&D Germany Gmbh | Apparatus for supplying a breathing gas and method for controlling the same |
US7621270B2 (en) * | 2003-06-23 | 2009-11-24 | Invacare Corp. | System and method for providing a breathing gas |
US7152598B2 (en) | 2003-06-23 | 2006-12-26 | Invacare Corporation | System and method for providing a breathing gas |
US8678003B2 (en) | 2003-11-25 | 2014-03-25 | Resmed Limited | Vent system for CPAP patient interface used in treatment of sleep disordered breathing |
DE102004014538A1 (en) * | 2004-03-23 | 2005-10-13 | Seleon Gmbh | Method for controlling a BiLevel device and BiLevel device |
US8800564B2 (en) * | 2005-03-09 | 2014-08-12 | Elaine D. Scott | Tracheostomy appliances and methods for the treatment of sleep apnea syndromes |
US7810497B2 (en) * | 2006-03-20 | 2010-10-12 | Ric Investments, Llc | Ventilatory control system |
US8069853B2 (en) * | 2006-08-14 | 2011-12-06 | Immediate Response Technologies | Breath responsive powered air-purifying respirator |
US20080060647A1 (en) * | 2006-09-12 | 2008-03-13 | Invacare Corporation | System and method for delivering a breathing gas |
US20080066751A1 (en) * | 2006-09-18 | 2008-03-20 | Invacare Corporation | System and method for humidifying a breathing gas |
US20080078384A1 (en) | 2006-09-18 | 2008-04-03 | Invacare Corporation | Breathing gas delivery system with user feedback |
DE202007004247U1 (en) * | 2007-03-22 | 2007-05-24 | Bartec Gmbh | Respirator e.g. for intensive care units, has feeding arrangement to supply air to patient, discharge equipment to remove expiration air from patient and sensor to determine condensation of supplied air and or expiration air |
EP2144674A4 (en) * | 2007-04-13 | 2012-12-26 | Invacare Corp | Apparatus and method for providing positive airway pressure |
WO2009026582A1 (en) * | 2007-08-23 | 2009-02-26 | Invacare Corporation | Method and apparatus for adjusting desired pressure in positive airway pressure devices |
US9717896B2 (en) | 2007-12-18 | 2017-08-01 | Gearbox, Llc | Treatment indications informed by a priori implant information |
US20090287109A1 (en) * | 2008-05-14 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US8636670B2 (en) | 2008-05-13 | 2014-01-28 | The Invention Science Fund I, Llc | Circulatory monitoring systems and methods |
US20090287120A1 (en) * | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287101A1 (en) * | 2008-05-13 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287094A1 (en) * | 2008-05-15 | 2009-11-19 | Seacrete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090292212A1 (en) * | 2008-05-20 | 2009-11-26 | Searete Llc, A Limited Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20090287191A1 (en) * | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
EP2320791B1 (en) | 2008-06-06 | 2016-08-31 | Covidien LP | Systems for ventilation in proportion to patient effort |
US8528554B2 (en) * | 2008-09-04 | 2013-09-10 | Covidien Lp | Inverse sawtooth pressure wave train purging in medical ventilators |
US8181648B2 (en) | 2008-09-26 | 2012-05-22 | Nellcor Puritan Bennett Llc | Systems and methods for managing pressure in a breathing assistance system |
US8302602B2 (en) | 2008-09-30 | 2012-11-06 | Nellcor Puritan Bennett Llc | Breathing assistance system with multiple pressure sensors |
US8113062B2 (en) | 2008-09-30 | 2012-02-14 | Nellcor Puritan Bennett Llc | Tilt sensor for use with proximal flow sensing device |
US8517017B2 (en) | 2009-01-08 | 2013-08-27 | Hancock Medical, Inc. | Self-contained, intermittent positive airway pressure systems and methods for treating sleep apnea, snoring, and other respiratory disorders |
US8776790B2 (en) * | 2009-07-16 | 2014-07-15 | Covidien Lp | Wireless, gas flow-powered sensor system for a breathing assistance system |
GB0915819D0 (en) * | 2009-09-10 | 2009-10-07 | Smiths Medical Int Ltd | Breathing apparatus |
US8439036B2 (en) | 2009-12-01 | 2013-05-14 | Covidien Lp | Exhalation valve assembly with integral flow sensor |
US8469031B2 (en) * | 2009-12-01 | 2013-06-25 | Covidien Lp | Exhalation valve assembly with integrated filter |
US20110126832A1 (en) * | 2009-12-01 | 2011-06-02 | Nellcor Puritan Bennett Llc | Exhalation Valve Assembly |
US8469030B2 (en) | 2009-12-01 | 2013-06-25 | Covidien Lp | Exhalation valve assembly with selectable contagious/non-contagious latch |
US8439037B2 (en) | 2009-12-01 | 2013-05-14 | Covidien Lp | Exhalation valve assembly with integrated filter and flow sensor |
BR112012013548B1 (en) * | 2009-12-07 | 2020-03-24 | Koninklijke Philips N.V. | PRESSURE SUPPORT SYSTEM |
EP2550052B1 (en) | 2010-03-25 | 2021-03-03 | ResMed Paris SAS | Breathable gas inlet control device for respiratory treatment apparatus |
USD655405S1 (en) | 2010-04-27 | 2012-03-06 | Nellcor Puritan Bennett Llc | Filter and valve body for an exhalation module |
USD655809S1 (en) | 2010-04-27 | 2012-03-13 | Nellcor Puritan Bennett Llc | Valve body with integral flow meter for an exhalation module |
USD653749S1 (en) | 2010-04-27 | 2012-02-07 | Nellcor Puritan Bennett Llc | Exhalation module filter body |
US8905019B2 (en) * | 2010-05-11 | 2014-12-09 | Carefusion 207, Inc. | Patient circuit integrity alarm using exhaled CO2 |
GB201020201D0 (en) * | 2010-11-30 | 2011-01-12 | Airbus Uk Ltd | Data transmission network |
US9907511B2 (en) * | 2010-12-17 | 2018-03-06 | Koninklijke Philips N.V. | System and method of identifying breaths based solely on capnographic information |
US8336546B2 (en) | 2011-02-08 | 2012-12-25 | Hancock Medical, Inc. | Positive airway pressure system with head control |
US8783250B2 (en) | 2011-02-27 | 2014-07-22 | Covidien Lp | Methods and systems for transitory ventilation support |
US9084859B2 (en) | 2011-03-14 | 2015-07-21 | Sleepnea Llc | Energy-harvesting respiratory method and device |
US8714154B2 (en) | 2011-03-30 | 2014-05-06 | Covidien Lp | Systems and methods for automatic adjustment of ventilator settings |
WO2012139023A2 (en) * | 2011-04-06 | 2012-10-11 | The Research Foundation Of State University Of New York | Device and method for determining processing capacity |
US9629971B2 (en) | 2011-04-29 | 2017-04-25 | Covidien Lp | Methods and systems for exhalation control and trajectory optimization |
US8776792B2 (en) | 2011-04-29 | 2014-07-15 | Covidien Lp | Methods and systems for volume-targeted minimum pressure-control ventilation |
US9364624B2 (en) | 2011-12-07 | 2016-06-14 | Covidien Lp | Methods and systems for adaptive base flow |
US9498589B2 (en) | 2011-12-31 | 2016-11-22 | Covidien Lp | Methods and systems for adaptive base flow and leak compensation |
US9022031B2 (en) | 2012-01-31 | 2015-05-05 | Covidien Lp | Using estimated carinal pressure for feedback control of carinal pressure during ventilation |
US8844526B2 (en) | 2012-03-30 | 2014-09-30 | Covidien Lp | Methods and systems for triggering with unknown base flow |
US10362967B2 (en) | 2012-07-09 | 2019-07-30 | Covidien Lp | Systems and methods for missed breath detection and indication |
CN110013591A (en) * | 2012-11-15 | 2019-07-16 | 宾夕法尼亚大学理事会 | Nose pulsation oxygenation and air flue air-breather |
US10314989B2 (en) | 2013-01-28 | 2019-06-11 | Hancock Medical, Inc. | Position control devices and methods for use with positive airway pressure systems |
US9492629B2 (en) | 2013-02-14 | 2016-11-15 | Covidien Lp | Methods and systems for ventilation with unknown exhalation flow and exhalation pressure |
US9981096B2 (en) | 2013-03-13 | 2018-05-29 | Covidien Lp | Methods and systems for triggering with unknown inspiratory flow |
US9950135B2 (en) | 2013-03-15 | 2018-04-24 | Covidien Lp | Maintaining an exhalation valve sensor assembly |
US9170193B2 (en) | 2013-06-06 | 2015-10-27 | General Electric Company | Detecting coolant leaks in turbine generators |
US9097657B2 (en) | 2013-07-23 | 2015-08-04 | General Electric Company | Leak detection of stator liquid cooling system |
US11291786B2 (en) | 2014-03-11 | 2022-04-05 | Koninklijke Philips N.V. | Reducing hypercapnic respiratory failure during mechanical ventilation |
US9808591B2 (en) | 2014-08-15 | 2017-11-07 | Covidien Lp | Methods and systems for breath delivery synchronization |
US10881829B2 (en) | 2014-08-18 | 2021-01-05 | Resmed Inc. | Portable pap device with humidification |
US9950129B2 (en) | 2014-10-27 | 2018-04-24 | Covidien Lp | Ventilation triggering using change-point detection |
US9925346B2 (en) | 2015-01-20 | 2018-03-27 | Covidien Lp | Systems and methods for ventilation with unknown exhalation flow |
USD776802S1 (en) | 2015-03-06 | 2017-01-17 | Hancock Medical, Inc. | Positive airway pressure system console |
EP4186548A1 (en) | 2015-04-02 | 2023-05-31 | Hill-Rom Services PTE. LTD. | Mask leakage detection for a respiratory device |
WO2017093862A1 (en) * | 2015-12-02 | 2017-06-08 | Koninklijke Philips N.V. | Method of co2 measurement during non-invasive ventilation |
WO2017201419A1 (en) | 2016-05-19 | 2017-11-23 | Hancock Medical, Inc. | Positional obstructive sleep apnea detection system |
KR101876553B1 (en) * | 2017-01-25 | 2018-08-02 | 한림대학교 산학협력단 | Apparatus and method for controlling ouput of lighting source in system for measuring partial pressure of respiratory gas |
EP3372988B1 (en) * | 2017-03-10 | 2022-10-12 | Sensatronic GmbH | Method and device for measuring the concentration of a substance in a gaseous medium by means of absorption spectroscopy |
EP3793656A1 (en) | 2018-05-14 | 2021-03-24 | Covidien LP | Systems and methods for respiratory effort detection utilizing signal distortion |
US11752287B2 (en) | 2018-10-03 | 2023-09-12 | Covidien Lp | Systems and methods for automatic cycling or cycling detection |
US11324954B2 (en) | 2019-06-28 | 2022-05-10 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
US11318276B2 (en) | 2020-08-05 | 2022-05-03 | Effortless Oxygen, Llc | Flow triggered gas delivery |
US11420007B2 (en) | 2020-08-05 | 2022-08-23 | Effortless Oxygen, Llc | Flow triggered gas delivery |
US11247008B1 (en) | 2020-08-05 | 2022-02-15 | Effortless Oxygen, Llc | Flow triggered gas delivery |
CN116944187B (en) * | 2023-09-19 | 2023-12-05 | 山西北都科技股份有限公司 | Roasting is with inhaling overhead traveling crane dust collector of unloading |
Family Cites Families (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US537213A (en) * | 1895-04-09 | Wind-board adjuster | ||
US761270A (en) * | 1903-10-19 | 1904-05-31 | Joshua S Towle | Rein-guard attachment for vehicles. |
US3921628A (en) * | 1971-08-19 | 1975-11-25 | Philips Corp | Medical ventilators |
US3822698A (en) | 1973-01-22 | 1974-07-09 | R Guy | Powered air-purifying respirator helmet |
DE2442589C3 (en) * | 1974-09-05 | 1979-09-06 | Draegerwerk Ag, 2400 Luebeck | Arrangement for measuring the CO2 content in breathing gases |
US4121578A (en) * | 1976-10-04 | 1978-10-24 | The Bendix Corporation | Physiological responsive control for an oxygen regulator |
US4350166A (en) * | 1980-12-12 | 1982-09-21 | Honeywell Inc. | Apnea detector |
WO1982003548A1 (en) | 1981-04-24 | 1982-10-28 | Sullivan Colin Edward | Device for treating snoring sickness |
US4506678A (en) * | 1982-06-07 | 1985-03-26 | Healthdyne, Inc. | Patient monitor for providing respiration and electrocardiogram signals |
US4713558A (en) | 1982-07-09 | 1987-12-15 | Healthdyne, Inc. | Patient monitor for providing respiration and electrocardiogram signals |
EP0100649B1 (en) * | 1982-07-30 | 1989-01-18 | Ronald Dunbar Rae | Fluid flow regulator |
US4590951A (en) | 1983-06-07 | 1986-05-27 | Racal Safety Limited | Breathing apparatus |
US4655213A (en) * | 1983-10-06 | 1987-04-07 | New York University | Method and apparatus for the treatment of obstructive sleep apnea |
US4648396A (en) * | 1985-05-03 | 1987-03-10 | Brigham And Women's Hospital | Respiration detector |
JPH0724099B2 (en) * | 1985-08-06 | 1995-03-15 | 富士写真フイルム株式会社 | Magnetic recording tape |
JPH0432697Y2 (en) * | 1985-12-05 | 1992-08-06 | ||
US4773411A (en) | 1986-05-08 | 1988-09-27 | Downs John B | Method and apparatus for ventilatory therapy |
US4728499A (en) * | 1986-08-13 | 1988-03-01 | Fehder Carl G | Carbon dioxide indicator device |
US4994117A (en) * | 1986-08-13 | 1991-02-19 | Fehder Carl G | Quantitative carbon dioxide detector |
US5166075A (en) | 1986-08-13 | 1992-11-24 | Nellcor Incorporated | Method for determining whether respiratory gas is present in a gaseous sample |
US5179002A (en) * | 1986-08-13 | 1993-01-12 | Nellcor Incorporated | Apparatus for determining whether respiratory gas is present in a gaseous sample |
US4817013A (en) | 1986-10-17 | 1989-03-28 | Nellcor, Inc. | Multichannel gas analyzer and method of use |
SE8700419D0 (en) * | 1987-02-04 | 1987-02-04 | Alfa Laval Thermal Ab | STANDARD OR PRESSURE PLATE FOR A PLATE HEAT EXCHANGER |
GB8704104D0 (en) * | 1987-02-21 | 1987-03-25 | Manitoba University Of | Respiratory system load apparatus |
US5199424A (en) | 1987-06-26 | 1993-04-06 | Sullivan Colin E | Device for monitoring breathing during sleep and control of CPAP treatment that is patient controlled |
US5522382A (en) * | 1987-06-26 | 1996-06-04 | Rescare Limited | Device and method for treating obstructed breathing having a delay/ramp feature |
US5065756A (en) | 1987-12-22 | 1991-11-19 | New York University | Method and apparatus for the treatment of obstructive sleep apnea |
US4821736A (en) * | 1988-03-22 | 1989-04-18 | Dale Medical Products, Inc. | Head-mounted device for supporting breathing circuit tubes and sensor |
GB8815179D0 (en) | 1988-06-25 | 1988-08-03 | Racal Safety Ltd | Differential pressure sensor |
US5124129A (en) * | 1988-07-29 | 1992-06-23 | Mallinckrodt Medical, Inc. | Carbon dioxide indicator |
US5094235A (en) * | 1989-05-10 | 1992-03-10 | Dragerwerk Aktiengesellschaft | Anesthesia ventilating apparatus having a breathing circuit and control loops for anesthetic gas components |
US5134995A (en) | 1989-05-19 | 1992-08-04 | Puritan-Bennett Corporation | Inspiratory airway pressure system with admittance determining apparatus and method |
US5845636A (en) | 1989-05-19 | 1998-12-08 | Puritan Bennett Corporation | Method and apparatus for maintaining patient airway patency |
US5259373A (en) * | 1989-05-19 | 1993-11-09 | Puritan-Bennett Corporation | Inspiratory airway pressure system controlled by the detection and analysis of patient airway sounds |
ES2129393T3 (en) | 1989-05-19 | 1999-06-16 | Puritan Bennett Corp | PRESSURE SYSTEM FOR INSPIRATORY ROUTES. |
US5632269A (en) * | 1989-09-22 | 1997-05-27 | Respironics Inc. | Breathing gas delivery method and apparatus |
US5148802B1 (en) | 1989-09-22 | 1997-08-12 | Respironics Inc | Method and apparatus for maintaining airway patency to treat sleep apnea and other disorders |
USRE35295E (en) | 1989-09-22 | 1996-07-16 | Respironics, Inc. | Sleep apnea treatment apparatus |
US5239995A (en) * | 1989-09-22 | 1993-08-31 | Respironics, Inc. | Sleep apnea treatment apparatus |
US5117819A (en) * | 1990-09-10 | 1992-06-02 | Healthdyne, Inc. | Nasal positive pressure device |
BR9005370A (en) * | 1990-10-18 | 1992-06-16 | Metal Leve Sa | COOLED PUMP MANUFACTURING PROCESS |
US5193544A (en) * | 1991-01-31 | 1993-03-16 | Board Of Trustees Of The Leland Stanford Junior University | System for conveying gases from and to a subject's trachea and for measuring physiological parameters in vivo |
EP0502270B1 (en) * | 1991-03-07 | 1997-01-02 | Hamamatsu Photonics K.K. | Tissue oxygen measuring system |
US5332901A (en) * | 1991-03-15 | 1994-07-26 | Li-Cor, Inc. | Gas analyzing apparatus and method for simultaneous measurement of carbon dioxide and water |
FI921924A (en) * | 1991-05-08 | 1992-11-09 | Nellcor Inc | PORTABEL COLDIOXIDE MONITOR |
US5458137A (en) * | 1991-06-14 | 1995-10-17 | Respironics, Inc. | Method and apparatus for controlling sleep disorder breathing |
US5203343A (en) * | 1991-06-14 | 1993-04-20 | Board Of Regents, The University Of Texas System | Method and apparatus for controlling sleep disorder breathing |
US6085747A (en) * | 1991-06-14 | 2000-07-11 | Respironics, Inc. | Method and apparatus for controlling sleep disorder breathing |
DE4133235A1 (en) | 1991-10-07 | 1993-04-08 | Draegerwerk Ag | FAN-SUPPORTED BREATHING DEVICE WITH AN ADD-ON CONTROL UNIT |
US5279289A (en) * | 1991-10-15 | 1994-01-18 | Kirk Gilbert M | Resuscitator regulator with carbon dioxide detector |
US6123075A (en) * | 1991-10-15 | 2000-09-26 | Mallinckrodt, Inc. | Resuscitator regulator with carbon dioxide detector |
DE69231157T2 (en) | 1991-11-14 | 2001-02-15 | Univ Technologies Int | AUTOMATIC SYSTEM FOR GENERATING CONTINUOUS POSITIVE AIRWAY PRESSURE |
US5372130A (en) | 1992-02-26 | 1994-12-13 | Djs&T Limited Partnership | Face mask assembly and method having a fan and replaceable filter |
US5490502A (en) | 1992-05-07 | 1996-02-13 | New York University | Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea |
US5335654A (en) * | 1992-05-07 | 1994-08-09 | New York University | Method and apparatus for continuous adjustment of positive airway pressure for treating obstructive sleep apnea |
US5803066A (en) * | 1992-05-07 | 1998-09-08 | New York University | Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea |
US5645054A (en) | 1992-06-01 | 1997-07-08 | Sleepnet Corp. | Device and method for the treatment of sleep apnea syndrome |
US5343878A (en) * | 1992-06-08 | 1994-09-06 | Respironics Inc. | Pressure application method |
FR2692152B1 (en) | 1992-06-15 | 1997-06-27 | Pierre Medical Sa | BREATHING AID, PARTICULARLY FOR TREATING SLEEP APNEA. |
US5353788A (en) | 1992-09-21 | 1994-10-11 | Miles Laughton E | Cardio-respiratory control and monitoring system for determining CPAP pressure for apnea treatment |
US5335650A (en) * | 1992-10-13 | 1994-08-09 | Temple University - Of The Commonwealth System Of Higher Education | Process control for liquid ventilation and related procedures |
US5517983A (en) * | 1992-12-09 | 1996-05-21 | Puritan Bennett Corporation | Compliance meter for respiratory therapy |
US5438980A (en) * | 1993-01-12 | 1995-08-08 | Puritan-Bennett Corporation | Inhalation/exhalation respiratory phase detection circuit |
US5558638A (en) | 1993-04-30 | 1996-09-24 | Healthdyne, Inc. | Patient monitor and support system |
US5394882A (en) * | 1993-07-21 | 1995-03-07 | Respironics, Inc. | Physiological monitoring system |
EP0920845B1 (en) * | 1993-11-05 | 2004-04-21 | ResMed Limited | Detection of apnea |
US6675797B1 (en) | 1993-11-05 | 2004-01-13 | Resmed Limited | Determination of patency of the airway |
DE69422900T2 (en) * | 1993-12-01 | 2000-06-08 | Resmed Ltd | Continuous positive airway pressure (CPAP) device |
US6237593B1 (en) * | 1993-12-03 | 2001-05-29 | Resmed Limited | Estimation of flow and detection of breathing CPAP treatment |
AUPM279393A0 (en) * | 1993-12-03 | 1994-01-06 | Rescare Limited | Estimation of flow and detection of breathing in cpap treatment |
US5535738A (en) * | 1994-06-03 | 1996-07-16 | Respironics, Inc. | Method and apparatus for providing proportional positive airway pressure to treat sleep disordered breathing |
US6105575A (en) | 1994-06-03 | 2000-08-22 | Respironics, Inc. | Method and apparatus for providing positive airway pressure to a patient |
US5794615A (en) * | 1994-06-03 | 1998-08-18 | Respironics, Inc. | Method and apparatus for providing proportional positive airway pressure to treat congestive heart failure |
US6932084B2 (en) | 1994-06-03 | 2005-08-23 | Ric Investments, Inc. | Method and apparatus for providing positive airway pressure to a patient |
US6866040B1 (en) | 1994-09-12 | 2005-03-15 | Nellcor Puritan Bennett France Developpement | Pressure-controlled breathing aid |
US5503146A (en) * | 1994-10-26 | 1996-04-02 | Devilbiss Health Care, Inc. | Standby control for CPAP apparatus |
US5551419A (en) * | 1994-12-15 | 1996-09-03 | Devilbiss Health Care, Inc. | Control for CPAP apparatus |
US5764795A (en) * | 1995-01-26 | 1998-06-09 | Fuji Xerox Co., Ltd. | Color image processing apparatus for color matching and color matching processing method |
US5947115A (en) * | 1995-01-26 | 1999-09-07 | Respironics, Inc. | Gas flow pressure filter |
US5537997A (en) * | 1995-01-26 | 1996-07-23 | Respironics, Inc. | Sleep apnea treatment apparatus and passive humidifier for use therewith |
US5540219A (en) * | 1995-01-26 | 1996-07-30 | Respironics, Inc. | Sleep apnea treatment apparatus |
US5558419A (en) * | 1995-01-30 | 1996-09-24 | Whirlpool Corporation | Pull-out freezer floor for refrigerator and freezers |
US5538000A (en) | 1995-02-06 | 1996-07-23 | Hans Rudolph, Inc. | Airflow delivery system |
JP3273295B2 (en) * | 1995-02-23 | 2002-04-08 | 日本光電工業株式会社 | Carbon dioxide concentration measurement device |
US5598838A (en) | 1995-04-07 | 1997-02-04 | Healthdyne Technologies, Inc. | Pressure support ventilatory assist system |
AUPN236595A0 (en) * | 1995-04-11 | 1995-05-11 | Rescare Limited | Monitoring of apneic arousals |
AUPN344195A0 (en) | 1995-06-08 | 1995-07-06 | Rescare Limited | Monitoring of oro-nasal respiration |
AUPN394895A0 (en) | 1995-07-03 | 1995-07-27 | Rescare Limited | Auto-calibration of pressure transducer offset |
AU6677596A (en) * | 1995-07-21 | 1997-02-18 | Respironics, Inc. | Method and apparatus for diode laser pulse oximetry using multifiber optical cables and disposable fiber optic probes |
US6095974A (en) * | 1995-07-21 | 2000-08-01 | Respironics, Inc. | Disposable fiber optic probe |
WO1997010868A1 (en) * | 1995-09-18 | 1997-03-27 | Resmed Limited | Pressure control in cpap treatment or assisted respiration |
AUPN616795A0 (en) * | 1995-10-23 | 1995-11-16 | Rescare Limited | Ipap duration in bilevel cpap or assisted respiration treatment |
US5953713A (en) * | 1995-10-26 | 1999-09-14 | Board Of Regents, The University Of Texas System | Method and apparatus for treatment of sleep disorder breathing employing artificial neural network |
US5865173A (en) * | 1995-11-06 | 1999-02-02 | Sunrise Medical Hhg Inc. | Bilevel CPAP system with waveform control for both IPAP and EPAP |
US5682878A (en) | 1995-12-07 | 1997-11-04 | Respironics, Inc. | Start-up ramp system for CPAP system with multiple ramp shape selection |
AUPN973596A0 (en) * | 1996-05-08 | 1996-05-30 | Resmed Limited | Control of delivery pressure in cpap treatment or assisted respiration |
AUPO163896A0 (en) | 1996-08-14 | 1996-09-05 | Resmed Limited | Determination of respiratory airflow |
US5765563A (en) | 1996-08-15 | 1998-06-16 | Nellcor Puritan Bennett Incorporated | Patient monitoring system |
US5694923A (en) | 1996-08-30 | 1997-12-09 | Respironics, Inc. | Pressure control in a blower-based ventilator |
US5701883A (en) * | 1996-09-03 | 1997-12-30 | Respironics, Inc. | Oxygen mixing in a blower-based ventilator |
AUPO418696A0 (en) * | 1996-12-12 | 1997-01-16 | Resmed Limited | A substance delivery apparatus |
US5937851A (en) * | 1997-02-27 | 1999-08-17 | Respironics, Inc. | Swivel device utilizing bearing clearance to allow carbon dioxide laden exhaust |
US5881717A (en) * | 1997-03-14 | 1999-03-16 | Nellcor Puritan Bennett Incorporated | System and method for adjustable disconnection sensitivity for disconnection and occlusion detection in a patient ventilator |
US6024089A (en) * | 1997-03-14 | 2000-02-15 | Nelcor Puritan Bennett Incorporated | System and method for setting and displaying ventilator alarms |
US6044843A (en) * | 1997-05-28 | 2000-04-04 | Nellcor Puritan Bennett Incorporated | Moisture resistant airway adapter for monitoring constituent gases |
US6135106A (en) * | 1997-08-22 | 2000-10-24 | Nellcor Puritan-Bennett, Inc. | CPAP pressure and flow transducer |
US5954050A (en) * | 1997-10-20 | 1999-09-21 | Christopher; Kent L. | System for monitoring and treating sleep disorders using a transtracheal catheter |
US6142952A (en) | 1997-10-29 | 2000-11-07 | The Board Of Regents, The University Of Texas System | Method and apparatus for detection and diagnosis of airway obstruction degree |
US6099481A (en) * | 1997-11-03 | 2000-08-08 | Ntc Technology, Inc. | Respiratory profile parameter determination method and apparatus |
AUPP026997A0 (en) | 1997-11-07 | 1997-12-04 | Resmed Limited | Administration of cpap treatment pressure in presence of apnea |
US6017315A (en) * | 1998-02-25 | 2000-01-25 | Respironics, Inc. | Patient monitor and method of using same |
AUPP240198A0 (en) | 1998-03-17 | 1998-04-09 | Resmed Limited | An apparatus for supplying breathable gas |
US6183423B1 (en) * | 1998-05-14 | 2001-02-06 | Respironics, Inc. | Breathing disorder prescreening device and method |
FI981234A (en) * | 1998-06-01 | 1999-12-02 | Nokia Networks Oy | Align Order |
AUPP512398A0 (en) | 1998-08-07 | 1998-09-03 | Resmed Limited | A control member for a valve and method for determining fluid flow rate through a valve |
US6257234B1 (en) * | 1998-08-21 | 2001-07-10 | Respironics, Inc. | Apparatus and method for determining respiratory mechanics of a patient and for controlling a ventilator based thereon |
US6155257A (en) * | 1998-10-07 | 2000-12-05 | Cprx Llc | Cardiopulmonary resuscitation ventilator and methods |
US7178524B2 (en) | 1998-10-30 | 2007-02-20 | Linda Noble | Nasal gas delivery system and method for use thereof |
US8701664B2 (en) | 1998-11-06 | 2014-04-22 | Caradyne (R&D) Limited | Apparatus and method for relieving dyspnoea |
US6212435B1 (en) * | 1998-11-13 | 2001-04-03 | Respironics, Inc. | Intraoral electromuscular stimulation device and method |
US6269811B1 (en) * | 1998-11-13 | 2001-08-07 | Respironics, Inc. | Pressure support system with a primary and a secondary gas flow and a method of using same |
US6102042A (en) * | 1998-12-22 | 2000-08-15 | Respironics, Inc. | Insufflation system, attachment and method |
US6071237A (en) * | 1999-02-19 | 2000-06-06 | Institute Of Critical Care Medicine | Device and method for assessing perfusion failure in a patient during endotracheal intubation |
US6347631B1 (en) | 1999-11-09 | 2002-02-19 | Mallinckrodt, Inc. | Cantilever device and method for breathing devices and the like |
CA2365348A1 (en) * | 1999-03-26 | 2001-01-04 | Gary L. Hansen | Cantilever device and method for breathing devices and the like |
US6467477B1 (en) | 1999-03-26 | 2002-10-22 | Respironics, Inc. | Breath-based control of a therapeutic treatment |
US6401713B1 (en) | 1999-05-05 | 2002-06-11 | Respironics, Inc. | Apparatus and method of providing continuous positive airway pressure |
SE9902180D0 (en) | 1999-06-10 | 1999-06-10 | Siemens Elema Ab | Apparatus for the supply of a breathing gas |
US20070000494A1 (en) | 1999-06-30 | 2007-01-04 | Banner Michael J | Ventilator monitor system and method of using same |
EP1189649B1 (en) | 1999-06-30 | 2005-06-15 | University Of Florida Research Foundation, Inc. | Ventilator monitor system |
US6615831B1 (en) | 1999-07-02 | 2003-09-09 | Respironics, Inc. | Pressure support system and method and a pressure control valve for use in such system and method |
US6644312B2 (en) | 2000-03-07 | 2003-11-11 | Resmed Limited | Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep |
US6532956B2 (en) | 2000-03-30 | 2003-03-18 | Respironics, Inc. | Parameter variation for proportional assist ventilation or proportional positive airway pressure support devices |
EP3156092A1 (en) | 2000-04-26 | 2017-04-19 | The University of Manitoba | Apparatus for determining respiratory system resistance during assisted ventilation |
DE10031079A1 (en) | 2000-06-30 | 2002-02-07 | Map Gmbh | Measuring patient breathing and state, correlates present respiration signals with prior reference measurements, to adjust CPAP therapy pressure accordingly |
US6349724B1 (en) | 2000-07-05 | 2002-02-26 | Compumedics Sleep Pty. Ltd. | Dual-pressure blower for positive air pressure device |
US6435184B1 (en) | 2000-09-01 | 2002-08-20 | Tien Lu Ho | Gas mask structure |
US6752151B2 (en) | 2000-09-25 | 2004-06-22 | Respironics, Inc. | Method and apparatus for providing variable positive airway pressure |
NZ524990A (en) | 2000-09-28 | 2005-02-25 | Invacare Corp | Carbon dioxide-based BI-level CPAP control |
US6626175B2 (en) | 2000-10-06 | 2003-09-30 | Respironics, Inc. | Medical ventilator triggering and cycling method and mechanism |
US6581595B1 (en) * | 2000-11-14 | 2003-06-24 | Sensormedics Corporation | Positive airway pressure device with indirect calorimetry system |
US6518733B1 (en) | 2001-08-03 | 2003-02-11 | Linear Technology Corporation | Circuits and techniques for capacitor charging circuits |
US7938114B2 (en) | 2001-10-12 | 2011-05-10 | Ric Investments Llc | Auto-titration bi-level pressure support system and method of using same |
US7168429B2 (en) | 2001-10-12 | 2007-01-30 | Ric Investments, Llc | Auto-titration pressure support system and method of using same |
US6834646B2 (en) | 2001-12-19 | 2004-12-28 | Testa Technologies T.T. Ltd. | Respiratory hood |
US6745770B2 (en) | 2002-01-08 | 2004-06-08 | Resmed Limited | Flow diverter for controlling the pressure and flow rate in a CPAP device |
US7438073B2 (en) | 2002-03-08 | 2008-10-21 | Kaerys S.A. | Air assistance apparatus for computing the airflow provided by only means of pressure sensors |
US6968842B1 (en) | 2002-04-03 | 2005-11-29 | Ric Investments, Inc. | Measurement of a fluid parameter in a pressure support system |
US6766800B2 (en) | 2002-08-30 | 2004-07-27 | Sensormedics Corporation | Pressure regulating valve for use in continuous positive airway pressure devices |
US6880544B2 (en) | 2002-12-10 | 2005-04-19 | Lang Manufacturing Company | Rack oven |
AU2004208574B2 (en) | 2003-01-30 | 2007-08-30 | Compumedics Limited | Algorithm for automatic positive air pressure titration |
US7524292B2 (en) | 2003-04-21 | 2009-04-28 | Medtronic, Inc. | Method and apparatus for detecting respiratory disturbances |
US7621270B2 (en) | 2003-06-23 | 2009-11-24 | Invacare Corp. | System and method for providing a breathing gas |
US7152598B2 (en) | 2003-06-23 | 2006-12-26 | Invacare Corporation | System and method for providing a breathing gas |
WO2005007056A2 (en) | 2003-07-22 | 2005-01-27 | Zinder, Oren | A respiratory aid system and method |
US7118536B2 (en) | 2003-07-25 | 2006-10-10 | Ric Investments, Llc. | Apnea/hypopnea detection system and method |
US7757690B2 (en) | 2003-09-18 | 2010-07-20 | Cardiac Pacemakers, Inc. | System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep |
US8011366B2 (en) | 2004-02-04 | 2011-09-06 | Devilbiss Healthcare Llc | Method for acclimating a CPAP therapy patient to prescribed pressure |
US8479727B2 (en) | 2004-05-04 | 2013-07-09 | The United States Of America As Represented By The Secretary Of The Army | Enhanced chemical/biological respiratory protection system |
GB0505724D0 (en) * | 2005-03-19 | 2005-04-27 | Smiths Group Plc | Tracheostomy tubes |
US7028688B1 (en) | 2005-04-05 | 2006-04-18 | The United States Of America As Represented By The Secretary Of The Army | Operationally adaptable chemical-biological mask |
BRPI0709500A2 (en) | 2006-04-10 | 2011-07-26 | Aeiomed Inc | apparatus for providing positive airway pressure for the treatment of sleep apnea, chronic pulmonary obstruction and snoring, and method for providing positive air pressure for the treatment of sleep apnea, chronic pulmonary obstruction and snoring |
US20080060647A1 (en) | 2006-09-12 | 2008-03-13 | Invacare Corporation | System and method for delivering a breathing gas |
EP2144674A4 (en) | 2007-04-13 | 2012-12-26 | Invacare Corp | Apparatus and method for providing positive airway pressure |
WO2009026582A1 (en) | 2007-08-23 | 2009-02-26 | Invacare Corporation | Method and apparatus for adjusting desired pressure in positive airway pressure devices |
-
2001
- 2001-09-27 NZ NZ524990A patent/NZ524990A/en unknown
- 2001-09-27 AU AU2001293203A patent/AU2001293203B2/en not_active Ceased
- 2001-09-27 EP EP01973647A patent/EP1322367A4/en not_active Withdrawn
- 2001-09-27 CA CA002421808A patent/CA2421808C/en not_active Expired - Fee Related
- 2001-09-27 AU AU9320301A patent/AU9320301A/en active Pending
- 2001-09-27 WO PCT/US2001/030768 patent/WO2002026287A2/en active IP Right Grant
- 2001-09-27 US US09/967,274 patent/US6990980B2/en not_active Expired - Fee Related
-
2005
- 2005-08-18 US US11/206,410 patent/US8640701B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1322367A2 (en) | 2003-07-02 |
AU2001293203B2 (en) | 2004-12-02 |
US20020104536A1 (en) | 2002-08-08 |
US6990980B2 (en) | 2006-01-31 |
WO2002026287A2 (en) | 2002-04-04 |
US20050279358A1 (en) | 2005-12-22 |
EP1322367A4 (en) | 2009-08-26 |
CA2421808A1 (en) | 2002-04-04 |
WO2002026287A3 (en) | 2002-08-22 |
NZ524990A (en) | 2005-02-25 |
AU9320301A (en) | 2002-04-08 |
US8640701B2 (en) | 2014-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2421808C (en) | Carbon dioxide-based bi-level cpap control | |
AU2001293203A1 (en) | Carbon Dioxide-Based Bi-Level CPAP Control | |
US6367474B1 (en) | Administration of CPAP treatment pressure in presence of APNEA | |
EP0656216B1 (en) | Estimation of flow and detection of breathing in CPAP treatment | |
JP5231256B2 (en) | Apnea / hypopnea determination during CPAP treatment | |
CA2649691C (en) | Method and system for controlling breathing | |
CA2908986C (en) | Positive airway pressure system and method for treatment of sleeping disorder in patient | |
CA2024477C (en) | Method and apparatus for providing breathing gas to a person, especially during treatment of sleep apnea | |
JP2019505297A (en) | Humidification of breathing gas | |
JPH09173456A (en) | Control method for breathing device and breathing device | |
CN107405107B (en) | Respirator and control method thereof | |
AU2004203313B2 (en) | Method and apparatus for providing breathing gas to a patient | |
AU779327B2 (en) | Administration of CPAP treatment pressure in presence of apnea | |
AU766227B2 (en) | Method and apparatus for providing breathing gas to a patient | |
AU734319B2 (en) | Method and apparatus for providing breathing gas to a patient | |
KR20210041371A (en) | Continuous positive airway pressure system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20120927 |